Sangamo Therapeutics, Inc. (SGMO)
OTCMKTS · Delayed Price · Currency is USD
0.1011
-0.0331 (-24.66%)
At close: May 7, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $41.88 million as of May 8, 2026. Its market cap has decreased by -75.28% in one year.
Market Cap
41.88M
Enterprise Value
47.73M
Revenue
39.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 41.88M, a decrease of -54.65%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 41.88M | -70.36% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 88.40M |
| BioStem Technologies | 69.70M |
| Nuo Therapeutics | 61.96M |
| Cell Source | 54.37M |
| ProText Mobility | 48.79M |
| Vicapsys Life Sciences | 47.26M |
| Provectus Biopharmaceuticals | 29.04M |
| Harvard Apparatus Regenerative Technology | 26.37M |